The association of interleukin-10 (IL-10) polymorphisms (-1082G/A, -819C/T, -592A/C) and interleukin-6 (IL-6) polymorphisms (-174G/C) with tuberculosis (TB) risk has been widely reported. However, the results are controversial. To clarify the role of these polymorphisms in TB, we performed a meta-analysis of all available and relevant published studies. Materials and Methods: Based on comprehensive searches of the PubMed, Medline, Embase, Web of Science, Elsevier Science Direct and Cochrane Library database, we identified outcome data from all articles estimating the association between IL-10 and IL-6 polymorphisms and TB risk.
INTRODUCTION
Tuberculosis (TB) is one of the important leading causes of death in humans, and it remains a serious public health obstacle in the developing countries. It is estimated that 1.4 million people annually die due to this treatable disease and 9 million incident cases of TB are estimated globally. 1 According to the report, Mycobacterium tuberculosis (MTB) infect about onethird of population; however, only approximately one-tenth of those infected will ever develop active TB, which indicate that MTB infection is the result of the interplay between host genetic susceptibility and environmental factors. Interleukin-10 (IL-10) is a multifunctional regulatory cytokine of inflammatory responses. Increasing numbers of studies 3 have demonstrated that IL-10 acts as a general inhibitor of proliferative and cytokine responses of both T helper (Th) 1 and Th2 cells in vitro and in vivo. IL-10 plays an anti-inflammatory action by suppressing the production of cytokines such as IL-1α, IL-1β, IL-6, IL-8, IL-12, and tumor necrosis factor-alpha in activated macrophage and interferon gamma in T cells. The IL-10 gene is located on chromosome 1 (1q31-1q32) with five exons. The promoter region of IL-10 gene has been found to be highly polymorphic and its many polymorphisms have been identified. 4 In the past few years, the impact of three common polymorphisms in the promoter of IL-10 gene -592A/C, -1082 G/A, and -819C/T on susceptibility to TB have been reported, and results suggested that these polymorphisms contribute to the risk of TB by affecting IL-10 transcription level, but the findings are controversial.
The human interleukin-6 (IL-6) gene is located at 7p21-24 locus with an upstream promoter containing 303 bp. IL-6 is a pleiotropic cytokine, secreted as a T-cell derived factor by a variety of cell types including lymphocytes, monocytes, and endothelial cells. It has endocrine as well as paracrine and autocrine actions implicated in several physiologic and pathologic processes including immunity and inflammation, activation of fibroblasts, mast cells, endothelial cells, monocytes, and keratinocytes. 5 Furthermore, the genetic polymorphism in the IL-6 promoter (-174G/C) that influences its transcription rate might play a crucial role in host immunity and susceptibility to TB. 6 A relatively large number of studies found the association between IL-10 and IL-6 polymorphisms and TB risk, however, the results have been inconsistent and inconclusive due to limited sample sizes and different study populations. Therefore, we performed this meta-analysis on all eligible case-control studies to estimate the effect of polymorphisms in the IL-10 and IL-6 genes on the risk of TB.
MATERIALS AND METHODS

Identification of relevant studies
Relevant publications were identified with a literature search using terms "IL-10" or "Interleukin-10" or "IL-6" or "Interleukin-6" and "tuberculosis" or "TB" or "TB infection" or "TB disease" and "polymorphism" or "genotype" or "variant" in the PubMed, Medline, Embase, Web of Science, Elsevier Science Direct and Cochrane Library database (the last search update was 1 February 2014), and the search was limited to Englishlanguage journals. Additional studies were identified by a manual search of the references of original studies. The following criteria were used for inclusion in the analysis: 1) a casecontrol or cohort design was used and 2) studies contained available genotype frequencies. The major reasons for exclusion of studies were: no usable data were reported.
Data extraction and quality assessment
Two investigators independently extracted data and jointly reached a consensus on all of the studies researched. The following data were collected from each study: first author's name, publication year, original country, ethnicity, number of cases and controls, genotype frequencies for cases and controls, Hardy-Weinberg equilibrium (HWE) of controls and Newcastle-Ottawa Scale (NOS). 7 Star symbol was used to denote the quality, based on 3 aspects of the study: selection, comparability, and exposure. Studies with a score of 7 stars or greater were considered to be of high quality.
Statistical analysis
The risks [odds ratios (ORs), and 95% confidence intervals (95% CIs)] of TB associated with IL-10 and IL-6 polymorphisms were estimated for each study based on extracted genotype data. The statistical significance of the pooled OR was determined using the Z-test. Heterogeneity assumption was examined by the Cochran's Q-test. If Q-test indicated p<0.10, thus indicating a lack of heterogeneity among studies, then the fixed effect model was used (the Mantel-Haenszel method). 8 Otherwise, the random-effects model (the DerSimonian and Laird method) 9 was performed. Sensitivity analysis was mainly performed to assess the stability of the results, namely, a single study in the meta-analysis was deleted to reflect the influence of the individual data set on the pooled OR. Asymmetry funnel plots were inspected to assess potential publication bias. The Egger's linear regression test was also used to assess publication bias statistically. All the above statistical analyses were performed by using the software Stata Version 12.0 (Stata Corporation, College Station, TX, USA) and p values were two-tailed.
RESULTS
Literature search and characteristics of eligible studies
The flow chart that displays the study selection process is shown in Fig. 1 NR, not report; PTB, pulmonary tuberculosis; EPTB, extra-pulmonary tuberculosis; SNP, single nucleotide polymorphism; PB, population-based controls; HB, hospital-based controls; PCR, polymerase chain reaction; SSP, sequence-specific primers; ARMS, amplification refractory mutation system; RFLP, restriction fragment length polymorphism; NOS, newcastle-ottawa scale; C, confirmed to HWE; HWE, Hardy-Weinberg equilibrium. 17, 26, 32, 33 The NOS scores ranged from 7 to 9, indicating that the methodological quality was generally good. The detailed characteristics of the eligible studies included in this meta-analysis are shown in Table 1 , and the genotype and allele distributions of all four polymorphisms are shown in Table 2 . The genotype distributions among the controls of all studies were consistent with the HWE except for eight studies for the IL-10 -1082G/A, 6, 11, 13, 23, 25, 27, 29, 34 one study for the IL-10 -819C/T, 36 three studies for the IL-10 -592A/C, 14, 33, 36 and two studies for the IL-6 -174G/C (Table 1) . 6, 16 Quantitative synthesis
The summary of the meta-analysis for IL-10 -1082G/A, -819C/T, -592A/C, and IL-6 -174G/C polymorphisms and tuberculosis susceptibility is shown in Table 3 .
Analysis of IL-10 -1082G/A and TB susceptibility
In all, twenty-six studies consisted of 5949 cases and 6948 controls, and assessed the potential influence of the IL-10 -1082G/ A polymorphism with TB susceptibility. Random effects models were used to calculate the pooled OR in all genetic models. Overall, the combined results showed no significant association in all genetic models ( Fig. 2A-E Table 3 .
Analysis of IL-10 -819C/T and TB susceptibility
As for IL-10 -819C/T, there were fifteen studies involving 4207 cases and 5264 controls for data synthesis in our meta-analysis.
The results showed that IL-10 -819C/T polymorphism was not significantly associated with the risk of TB in all genetic models (Fig. 2F-J Table 3 . 
Analysis of IL-10 -592A/C and TB susceptibility
In total, sixteen studies including 4115 cases and 5441 controls examined the relationship between the IL-10 -592A/C polymorphism and TB susceptibility. As shown in Table 3 , we failed to find the association between the IL-10 -592A/C polymorphism and TB risk in all genetic models. In the stratified analyses for the IL-10 -592A/C polymorphism, a significantly increased risk was observed among Asians in allele model (A allele vs. C allele: OR=1.26, 95% CI=1.08-1.28), homozygous model (AA vs. CC: OR=1.50, 95% CI=1.07-2.12), and recessive Table 3) . Table 3 .
Analysis of IL-6 -174G/C and TB susceptibility
Heterogeneity analysis
There were statistically significant heterogeneity in all genetic models for IL-10 -1082G/A polymorphism, heterozygous mod- (Table 3) . To elucidate the heterogeneity, Galbraith plots were performed in these genetic models. When the studies which were outliers in some genetic models were excluded respectively, all I 2 values were less than 50%, and Pheterogeneity were greater than 0.1 (Fig. 3, Table 4 ). The significance of pooled OR in all genetic models was not influenced after excluding the studies. By meta-regression analysis, the heterogeneity sources were attributable to the sample types, ethnicity, control source, and the genotyping method. Ethnicity and sample types might be predominant sources of heterogeneity in IL-10 -1082G/A polymorphism, and ethnicity and control source in both IL-10 -819C/T and IL-10 -592A/C polymorphisms (Table 5) . Fig. 3 . Galbraith plot of IL-10 promoter polymorphism and TB risk. (A-E) The five studies 18, 20, 22, 31, 33 in G vs. A, three studies 20, 22, 31 in GG vs. AA, seven studies 13, 18, 20, 22, 31, 33, 37 in AG vs. AA, six studies 13, 18, 20, 22, 31, 33 in GG+AG vs. AA, and five studies 20, 22, 27, 35, 37 in GG vs. AG+AA were outliers for -1082G/A. (F and G) The one study 38 in TC vs. CC and one study 38 in TT+TC vs. CC for -819C/T. (H-K) The three studies 26, 28, 38 in A vs. C, one study 38 in AA vs. CC, one study 38 in AA+AC vs. CC, and two studies 17, 38 in AA vs. AC+CC for -592A/C. TB, tuberculosis; IL-10, interleukin 10. 
Sensitivity analysis
Sensitivity analysis was performed by sequentially excluding individual studies, including studies which was not in agreement with HWE. Statistically similar results were obtained in all genetic models after sequentially excluding each study, indicating the stability of our data.
Publication bias
Begg's funnel plot and Egger's test were performed to assess the publication bias of included studies. The shapes of the funnel plots did not reveal any evidence of obvious asymmetry in the all genetic models. In all genetic models, Egger's test also did not show any significant statistical evidence of publication bias, indicating low risk of publication bias in this meta-analysis (Fig. 4 , Table 6 ).
DISCUSSION
This is not the first meta-analysis to assess the associations between three polymorphisms (-1082G/A, -819C/T, and -592A/C) in the IL-10 gene promoter and the risk of TB. We found that the results of our meta-analysis are inconsistent with a recent study of Liang, et al. 39 in which some following shortcomings were found : 1) the NOS scores of 3 Chinese articles included were lower than 7 stars through quality assessment, 2) two studies that meet the inclusion criterion were excluded (Ma, et al., 28 Spinassé, et al.
32
), 3) the choice of genetic models was incorrect, 4) heterogeneity analysis and sensitivity analysis were missing, and 5) some extracted data was not accurate enough. Therefore, we performed this meta-analysis to examine the association between three IL-10 and IL-6 polymorphisms and TB risk again. Our meta-analysis results indicated that the presence of the IL-10 -1082G/A, -819C/T, and -592A/C polymorphisms was not associated with the risk of TB in all genetic models. On the other hand, the IL-6 -174G/C polymorphism might be associated with an decreased risk of TB in some genetic models (C allele vs. G allele: OR=0.77, 95% CI=0.64-0.91, p=0.003; CC vs. GG: OR=0.72, 95% CI=0.57-0.90, p=0.005; CC+CG vs. GG: OR=0.71, 95% CI=0.57-0.88, p=0.002).
We also carried out subgroup analysis based on ethnicity, sample types and control source in consideration of obvious heterogeneity. In the stratiied analysis by ethnicity, we observed significantly increased TB risk associated with the IL-10 -1082G/A polymorphism in recessive model in Europeans, IL-10 -819C/T polymorphism in Asians in heterozygous model and dominant model, IL-10 -592A/C polymorphism in Asians in Allele model, homozygous model and recessive model respectively, and a decreased TB risk associated with IL-6 -174G/ C polymorphism was found in allele model, heterozygous model and dominant model in Asians. Different genetic background and environmental exposures might contribute to this ethnic difference. Subgroup analysis based on sample types suggested that IL-10 -1082G/A polymorphism may be related with an increased risk of TB in homozygous model in the PTB+EPTB mixed sample. The results of subgroup analysis by control source revealed no signiicant association with TB susceptibility among IL-10 and IL-6 polymorphisms.
In our meta-analysis, obvious heterogeneity was observed for IL-10 -1082G/A polymorphism in all genetic models, -819C/T polymorphism in heterozygous model and dominant model, and -592A/C polymorphism in all genetic models except for heterozygous model, whereas there was no obvious heterogeneity for IL-6 -174G/C polymorphism. Then, we used the Galbraith plots to explore the sources of heterogeneity. We found that all the I 2 values were less than 50% and Pheterogeneity were greater than 0.1 after excluding some studies, thus indicating that these studies might be the major source of the heterogeneity for the IL-10 -1082G/A, -819C/T, and -592A/C polymorphisms. Owing to the limited number of studies in this metaanalysis, we restricted meta-regression analysis to four factors (sample types, ethnicity, control source, and genotyping method), which are the most likely to cause the heterogeneity between studies. Although the four above-mentioned factors had no significant impact on the heterogeneity except sample types factor for IL-10 -1082G/A in homozygous model, the results of subgroup analyses revealed that the ethnicity and sample type might contribute to the potential heterogeneity.
Some limitations of this meta-analysis exist which should be considered when interpreting the present results. Firstly, heterogeneity is a potential problem when interpreting the results of meta-analysis. Significant heterogeneity existed among some comparisons, especially for IL-10 -1082G/A and -592A/C polymorphisms. Secondly, this meta-analysis included the only published studies and publication bias may occur, although our results of publication bias showed no significance. Thirdly, host genetic susceptibility, environment factors and other factors might contribute to the pathogenesis of TB. Although many other factors such as age or gender may play a profound role in the development of TB, we did not make subgroup analysis based on these factors as data is not sufficient. Finally, some genetic polymorphisms of studies deviant from HWE were included in this meta-analysis, which suggested that there was potential bias during control selection or genotyping errors.
In conclusion, our meta-analysis suggested that IL-10 -1082G/A, -819C/T, and -592A/C polymorphisms had no association with TB risk in general population, while the IL-6 -174G/C polymorphism was signiicantly associated with decreased risk of TB in all genetic models except for recessive model. In the subgroup analysis, IL-10 -1082G/A polymorphism was associated with TB risk in Europeans in recessive model, and IL-10 -592A/C polymorphisms were significantly associated with TB risk in Asians in Allele model, homozygous model and recessive model, respectively, and a decreased TB risk associated with IL-6 -174G/C polymorphism was found in allele model, heterozygous model and dominant model in Asians. Furthermore, IL-10 -1082G/A polymorphism was as- sociated also with an increased risk of TB in homozygous model in the PTB+EPTB mixed sample. However, additional well-designed and larger scale primary studies in populations with different ethnicities are required to further evaluate the IL-10 and IL-6 gene polymorphisms with TB risk in future. 
